Paclitaxel Ramucirumab TP53 angiogenesis gastric cancer

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
24 Jul 2020
Historique:
received: 10 06 2020
revised: 14 07 2020
accepted: 22 07 2020
entrez: 30 7 2020
pubmed: 30 7 2020
medline: 30 7 2020
Statut: epublish

Résumé

Loss of p53 promotes vascular endothelial growth factor (VEGF)-A up-regulation and the angiogenic potential of cancer cells. We investigated

Identifiants

pubmed: 32722340
pii: cancers12082049
doi: 10.3390/cancers12082049
pmc: PMC7465166
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Lancet Oncol. 2019 Mar;20(3):420-435
pubmed: 30718072
Ann Oncol. 2016 Mar;27(3):539-43
pubmed: 26646755
Expert Opin Biol Ther. 2019 Nov;19(11):1135-1141
pubmed: 31452409
J Clin Oncol. 2005 Dec 20;23(36):9067-72
pubmed: 16172462
Gastroenterology. 2015 Oct;149(5):1153-1162.e3
pubmed: 26073375
JCI Insight. 2019 Aug 8;4(15):
pubmed: 31391338
Oncotarget. 2013 May;4(5):705-14
pubmed: 23670029
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Angiogenesis. 2013 Jul;16(3):481-92
pubmed: 23389639
Nat Rev Clin Oncol. 2018 Jan;15(1):13-30
pubmed: 28948977
Cell Death Differ. 2013 Jul;20(7):888-97
pubmed: 23449391
Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):11015-20
pubmed: 16835303
Genes Dev. 2000 Jan 1;14(1):34-44
pubmed: 10640274
Br J Cancer. 2012 Nov 6;107(10):1722-8
pubmed: 23079576
Drug Resist Updat. 2020 Mar;49:100671
pubmed: 31841768
Target Oncol. 2018 Apr;13(2):227-234
pubmed: 29582224
Cancer Res. 2015 Apr 1;75(7):1187-90
pubmed: 25672981
Oncotarget. 2016 Jul 26;7(30):48577-48585
pubmed: 27191893
Carcinogenesis. 2016 Oct;37(10):972-984
pubmed: 27520561
Mol Cancer Ther. 2016 Oct;15(10):2475-2485
pubmed: 27466356
Drug Resist Updat. 2018 May;38:27-43
pubmed: 29857816
Nat Med. 1996 Jan;2(1):72-9
pubmed: 8564846
Br J Cancer. 2008 Nov 4;99(9):1402-7
pubmed: 18971936
J Mol Cell Biol. 2019 Apr 1;11(4):293-305
pubmed: 30508182
JCI Insight. 2018 Aug 9;3(15):
pubmed: 30089713
Cancer Biol Ther. 2020;21(1):95-100
pubmed: 31564192
Nature. 2014 Sep 11;513(7517):202-9
pubmed: 25079317
J Biol Chem. 2019 Jun 7;294(23):9064-9075
pubmed: 31023826
Genes Dev. 2015 Jun 15;29(12):1298-315
pubmed: 26080815
Clin Cancer Res. 2015 Aug 1;21(15):3372-6
pubmed: 26048277
Cancer Lett. 2009 Apr 18;276(2):143-51
pubmed: 19091459
Cancers (Basel). 2019 Jul 30;11(8):
pubmed: 31366114
Cancer Cell. 2014 Mar 17;25(3):304-17
pubmed: 24651012
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8424-9
pubmed: 12826609

Auteurs

Francesco Graziano (F)

Medical Oncology Unit, Azienda, Ospedali Riuniti Marche Nord, 61121 Pesaro, Italy.

Nicholas W Fischer (NW)

Genetics & Genome Biology Program, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.

Irene Bagaloni (I)

Department of Biomolecular Sciences, Università degli Studi di Urbino, 61032 Fano, Italy.

Maria Di Bartolomeo (M)

Department of Medical Oncology, Istituto Nazionale dei Tumori di Milano, 20133 Milan, Italy.

Sara Lonardi (S)

Veneto Institute of Oncology IOV-IRCCS, 35128 Padova, Italy.

Bruno Vincenzi (B)

Department of Oncology, Campus Bio-Medico University, 00128 Rome, Italy.

Giuseppe Perrone (G)

Department of Oncology, Campus Bio-Medico University, 00128 Rome, Italy.

Lorenzo Fornaro (L)

Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, 56126 Pisa, Italy.

Elena Ongaro (E)

Department of Oncology, University and General Hospital, 33100 Udine, Italy.
Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.

Giuseppe Aprile (G)

Department of Oncology, San Bortolo General Hospital, 36100 Vicenza, Italy.

Renato Bisonni (R)

Medical Oncology Unit, Hospital of Fermo, 63900 Fermo, Italy.

Michele Prisciandaro (M)

Department of Medical Oncology, Istituto Nazionale dei Tumori di Milano, 20133 Milan, Italy.

David Malkin (D)

Genetics & Genome Biology Program, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
Division of Hematology-Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada.

Jean Gariépy (J)

Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada.
Physical Sciences, Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.

Matteo Fassan (M)

Veneto Institute of Oncology IOV-IRCCS, 35128 Padova, Italy.

Fotios Loupakis (F)

Veneto Institute of Oncology IOV-IRCCS, 35128 Padova, Italy.

Donatella Sarti (D)

Medical Oncology Unit, Azienda, Ospedali Riuniti Marche Nord, 61121 Pesaro, Italy.

Michela Del Prete (M)

Medical Oncology Unit, Hospital of Fermo, 63900 Fermo, Italy.

Vincenzo Catalano (V)

Medical Oncology Unit, Azienda, Ospedali Riuniti Marche Nord, 61121 Pesaro, Italy.

Paolo Alessandroni (P)

Medical Oncology Unit, Azienda, Ospedali Riuniti Marche Nord, 61121 Pesaro, Italy.

Mauro Magnani (M)

Department of Biomolecular Sciences, Università degli Studi di Urbino, 61032 Fano, Italy.

Annamaria Ruzzo (A)

Department of Biomolecular Sciences, Università degli Studi di Urbino, 61032 Fano, Italy.

Classifications MeSH